ANAPTYSBIO, INC. (ANAB) Return on equity 2017–2025
ANAPTYSBIO, INC. (ANAB) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-35.6%FY2025 · since FY2017: -9.8% → -35.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -35.6% | +169.4 pp |
| FY2024 | -204.9% | -19.2 pp |
| FY2023 | -185.7% | -136.6 pp |
| FY2022 | -49.1% | -32.9 pp |
| FY2021 | -16.2% | -11.2 pp |
| FY2020 | -5.0% | +19.0 pp |
| FY2019 | -24.0% | -11.4 pp |
| FY2018 | -12.7% | -2.9 pp |
| FY2017 | -9.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice